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Research
Developmental neurotoxicity (DNT) of 
environmental chemicals has been recog-
nized worldwide as a serious threat to 
human health, and the resulting neurologic 
deficits negatively affect families and society 
(Goldman and Koduru 2000; Needleman 
et al. 2002). Current DNT testing guidelines 
(Organization for Economic Cooperation 
and Development 2007; U.S. Environmental 
Protection Agency 1998) propose investiga-
tions in rodents, mainly rats. Such a DNT 
in vivo testing strategy implies the use of 
140 dams and 1,000 pups and is therefore 
extremely time- and cost-intensive (Lein et al. 
2005). Relying solely on the existing guide-
lines to address current and anticipated future 
regulatory demands for DNT of the thou-
sands of chemicals for which there are few to 
no DNT data would incur unacceptable costs 
in terms of animals and person-years (Lein 
et al. 2007). Therefore, according to the “3R 
principle” (reduction, replacement, and refine-
ment) of Russel and Burch (1959), alternative 
testing strategies are needed to address ani-
mal welfare by refining and reducing animal 
experiments, and to create affordable, sensi-
tive, and mechanism-based methods suitable 
for high- or medium-throughput screening 
(Collins et al. 2008). Furthermore, the inclu-
sion of human-cell–based in vitro systems into 
an integrated DNT tiered testing approach 
has been recom  mended to circumvent species 
differences (Coecke et al. 2007).
To combine transatlantic strengths and 
avoid doubling of work, a partnership between 
the Johns Hopkins Center for Alternatives to 
Animal Testing (Developmental Neurotoxicity 
TestSmart program), the European Centre for 
the Validation of Alternative Methods, and the 
European Chemical Industry Council has been 
formed. This partnership follows the com-
mon goal of “incorporating in vitro alternative 
methods for DNT testing into inter  national 
hazard and risk assessment strategies” (Coecke 
et al. 2007). Coecke et al. (2007) provided a 
comprehensive overview of the existing in vitro 
models and stated that, “although all the test 
systems described were not developed for regu-
la  tory purposes at this stage if they prove use-
ful, we hope that this report will encourage 
their further development to render them ame-
nable to high-throughput approaches.”
Therefore, the aim of this work was a) to 
introduce the cell biological characteristics of 
human neurospheres as a three-dimensional 
cell system approach for DNT testing; b) to 
demonstrate that neurospheres are likely to 
mirror basic processes of brain development, 
such as proliferation, differentiation, migra-
tion, and apoptosis; and c) to demonstrate that 
these processes can be modulated by develop-
mental neuro  toxicants.
Materials and Methods
Chemicals. We obtained methylmercury chlo-
ride (MeHgCl) from Riedel-de Haën (Seelze, 
Germany); all other substances were obtained 
from Sigma Aldrich (Munich, Germany), 
unless otherwise stated.
Cell culture.  Cryo  preserved normal 
human neural progenitor cells (hNPCs; Lonza 
Verviers SPRL, Verviers, Belgium) were cul-
tured at 37°C and 5% CO2 as a suspension 
culture in proliferation medium consisting of 
Dulbecco’s modified Eagle medium (DMEM) 
and Hams F12 (3:1) supplemented with B27 
(Invitrogen GmbH, Karlsruhe, Germany), 
20 ng/mL epidermal growth factor (EGF; 
Biosource, Karlsruhe, Germany), and 20 ng/
mL recombinant human fibro  blast growth 
factor (FGF; R&D Systems, Wiesbaden-
Nordenstadt, Germany) (Moors et al. 2007). 
When spheres reached 0.7 mm in diameter, 
they were chopped up to passage 3 with a 
McIlwain tissue chopper. Differentiation was 
initiated by growth factor withdrawal in dif-
ferentiation medium [DMEM and Hams 
F12 (3:1) supplemented with N2 (insulin, 
transferrin, sodium selenite, putrescine, and 
progesterone; Invitrogen)] and plated onto 
poly-d-lysine/laminin–coated chamber slides 
(BD Bioscience, Erembodegem, Belgium).
Chemical exposure. We exposed cells to 
indirubin (10 µM) in proliferation medium 
(28 hr), and to cAMP (200 µM), MeHgCl 
(250 nM to 1 µM), mercury chloride (HgCl2; 
500 nM to 10 µM, 48 hr) or staurosporine 
(0.1 and 1 µM), or hydrogen peroxide 
(H2O2; 0.1 and 1 mM) (24 hr) in differentia-
tion medium. We chose concentration ranges 
of mercury according to Monnet-Tschudi 
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key w o r d s : apoptosis, differentiation, DNT, human neurospheres, mercury, migration, prolifera-
tion. Environ Health Perspect 117:1131–1138 (2009).  doi:10.1289/ehp.0800207 available via http://
dx.doi.org/ [Online 26 February 2009]Moors et al.
1132  v o l u m e  117 | n u m b e r 7 | July 2009  •  Environmental Health Perspectives
et al. (1996), who found a concentration of 
1 µM to be cytotoxic.
Migration analyses. Migration analy-
ses were performed as previously described 
(Moors et al. 2007). For living cell migra-
tion analyses, neurospheres were grown in the 
Focht Chamber System 2 (Bioptechs, Butler, 
PA, USA) under temperature- and CO2-
controlled conditions. Images were acquired 
every 2 min by a Zeiss Axiovert 100 inverted 
microscope (Zeiss, Goettingen, Germany).
Immunohistochemistry. Proliferating or dif-
ferentiating spheres were fixed in 4% paraform-
aldehyde for 30 min. After washing spheres in 
phosphate-buffered saline (PBS), they were 
incubated in a 25% sucrose solution (wt/vol) 
overnight at 4°C. Afterward, spheres were 
transferred to tissue-freezing medium (Jung 
HistoService, Nussloch, Germany). Cryostat 
sections (10 µm) were prepared for immuno-
histo  chemistry. Antibodies for staining were 
nestin (1:150; BD Bioscience), glial fibrillary 
acidic protein (GFAP; 1:100, Sigma Aldrich), 
or β(III)tubulin (1:100; Sigma Aldrich).
Immunocytochemistry/differentia-
tion analy  ses. We performed immunocyto-
chemistry as previously described (Fritsche 
et al. 2005; Moors et al. 2007). For quantifica-
tion analyses, we used the Metamorph analysis 
software package (version 7.1.7.0; Universal 
Imaging Corp., West Chester, PA, USA). We 
determined the variation of protein expres-
sion by relating area of fluorescence signal to 
cell number in a region of interest within the 
migration area. Individual pixels were iden-
tified as “positive” if the fluorescence signal 
exceeded a determined color threshold [green, 
hue (H) 71–113, saturation (S) 10–255, 
intensity (I) 10–255; yellow/red, H 0–71, 
S 10–255, I 10–255)]. To determine the cell 
number, we selected images for positive 4´,6-
diamidino-2-phenyl  indole (DAPI) staining 
(blue, H 152–180, S 10–255, I 10–255) and 
morphologic parameters (integrated morphol-
ogy analysis: area, 104 > n > 107; ellipsoid form 
factor, 0.1 > n > 1.8).
Fluorescence-activated cell sorting (FACS)/
cell cycle analyses. Proliferating neuro-
spheres were grown in proliferation media 
with or without growth factors or exposed 
to indirubin. To obtain a single-cell suspen-
sion, neurospheres were washed once in PBS, 
incubated with Accutase (100%; PAA, Cölbe, 
Germany) at 37°C for 20 min, and then gen-
tly pipetted. The suspension was centrifuged 
(4°C, 1,400 × g, 5 min) and the pellet was 
resuspended in PBS containing 0.8% para-
formaldehyde (Polyscience Inc., Eppelheim, 
Germany). Cells were fixed for 30 min at 4°C, 
centrifuged (4°C, 1,400 × g, 5 min), resus-
pended in PBS containing 0.15% saponin and 
10 µg/mL RNase, and incubated for 30 min 
at 37°C. We then added 50 µg/mL propidium 
iodine 5 min before FACS analyses.
Cell viability, apoptosis, and proliferation 
assays. We measured cell viability using the 
CellTiter-Blue assay (Promega, Mannheim, 
Germany) as previously described (Moors 
et al. 2007). The assay is based on measure-
ments of the mitochondrial reductase activity 
by conversion of the substrate resazurin to the 
fluorescent product resorufin by mitochon-
drial reductases, which can be assessed in a flu-
orometer. The lactate dehydrogenase (LDH) 
assay (CytoTox-One; Promega) assesses cell 
death by measuring LDH that leaks out of 
dead cells into the media. We performed the 
assay according to the manufacturer’s instruc-
tions. Briefly, supernatants of treated cells were 
collected and incubated with an equal amount 
of CytoTox-One reagent for 4 hr before the 
detection of fluorescence (excitation, 540 nm; 
emission, 590 nm). Caspase-3/-7 activi-
ties were measured with the Apo-One Kit 
(Promega) according to the manufacturer’s 
instructions. Briefly, cells were lysed and cas-
pase activity was assessed by measuring the 
cleavage of a caspase-3/-7–specific fluorescent 
substrate (Z-DEVD-R110) with a fluorometer 
(excitation, 488 nm; emission, 538 nm).
For proliferation assays, spheres were cul-
tured in proliferation medium supplemented 
with or without 20 or 100 ng/mL EGF in 
96-well plates. We assessed cell viability as a 
meas  ure for cell number using the CellTiter-
Blue assay at different time points. Because the 
dye caused no acute cytotoxicity, spheres were 
washed with medium after fluorescence read-
ing and then the same spheres were monitored 
over a period of 2 weeks. For determination of 
sphere size, we gauged sphere diameter opti-
cally with an object micrometer. We counted 
the number of cells/sphere after trypsination 
(0.25% trypsin; Invitrogen) for 2 min.
TUNEL assay. For terminal deoxy-
nucleo  tidyl transferase 2´-deoxyuridine 
5´-triphosphate (dUTP) nick end labeling 
(TUNEL) assays, we used fluorescein-coupled 
dUTP and the terminal transferase kit from 
Roche Diagnostics (Mannheim, Germany) to 
label DNA strand breaks; nuclei were counter-
stained with Hoechst 33258 (Invitrogen). 
Plated neurospheres were exposed to stauro-
sporine (1 µM) or H2O2 (1 mM) after 48 hr 
of differentiation. After another 12 and 
24 hr, cells were fixed with 4% paraform-
aldehyde, washed twice with PBS, covered 
with reaction mixture (2.5 mM CoCl2, 5 µM 
fluorescein coupled dUTP, 5,000 U/mL   
terminal-transferase, 2 µg/mL Hoechst, 0.1% 
triton in 1× terminal transferase buffer), and 
incubated at 37°C for 1 hr. Slides were then 
washed with PBS three times and mounted 
with PBS/glycerol (1:1). Stained cells were 
analyzed with a fluorescence microscope.
Statistics. We used analysis of variance 
combined with the Bonferroni post hoc 
test for multifactor analyses (time and 
concentration effects), and the Student’s t-test 
for two-group comparisons (treatment vs. 
control; two time points). The significance 
value was set at p < 0.05. To describe the asso-
ciations between independent variables (diam-
eter/cell number; diameter/fluorescence), we 
fitted curves up to the third degree. We used 
R2 as a measure of goodness of fit.
Results
Human neurospheres grow floating freely in 
defined medium without addition of serum 
[see Supplemental Material, Figure 1A 
(available at http://www.ehponline.org/
members/2009/0800207/suppl.pdf)]. Upon 
withdrawal of growth factor, cells migrate 
radially out of the sphere onto a poly-d-lysine/
laminin matrix, thereby forming a migration 
area [see Supplemental Material, Figure 1B 
and the video (available at http://www.   
ehponline.  org/members/  2009/0800207/
suppl.pdf)]. Each cell leaves the sphere edge 
in a 90° angle and travels away in a straight 
line. Moreover, cells move toward and away 
from each other.
To evaluate reproducibility and stability 
of neurosphere migration, we assessed depen-
dence of migration speed on neurosphere size. 
Therefore, the distance between the sphere 
edge and the farthest outgrown cells was meas-
ured 24 hr after plating, dependent on differ-
ent sphere diameters. Supplemental Material, 
Figure 1C (available at http://www.ehponline.
org/  members/  2009/  0800207/suppl.pdf) shows 
that spheres with a diameter between 0.2 and 
0.7 mm wander approximately 0.48 mm within 
24 hr (e.g., 0.2 mm diameter, 0.48 ± 0.06 mm; 
0.7 mm diameter, 0.48 ± 0.09 mm; mean ± 
SD), demon  strating that migration speed is 
independent of sphere size. Moreover, cells from 
different donors (0.3-mm-diameter spheres) 
also did not vary significantly in migration 
speed over 24 hr [see Supplemental Material, 
Figure 1D (available at http://www.ehponline.
org/members/2009/0800207/suppl.pdf)].
Next, we analyzed the cellular composi-
tion of neurospheres. We sliced 10-µm cryo-
stat sections of proliferating neuro  spheres and 
examined expressions of a) nestin, a marker 
protein for neural stem cells; b) β(III)tubulin, 
which stains neurons; or c) GFAP for glial 
cells. Immunocytochemical analy  ses revealed 
nestin-positive (+) cells were located mainly in 
the sphere periphery, whereas β(III)tubulin+ 
and GFAP+ cells resided in the sphere cen-
ter (Figure 1A,B). This pattern disappeared 
after spheres were plated for differentiation. 
After 8 days of differentiation, β(III)tubulin+ 
cells were located at the edge of the sphere, 
whereas nestin+ and GFAP+ cells were homog-
enously distributed throughout the sphere 
(Figure 1C,D).
In addition to the sphere itself, we 
investigated the cellular composition of the Human neurospheres for developmental neurotoxicity testing
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migration area after 24 hr and 7 days of migra-
tion. Twenty-four hours after plating, nearly 
all migrated cells seemed to express nestin, 
showing that immature cells migrate out of 
the sphere. Furthermore, β(III)tubulin+ and 
GFAP+ cells were also located in the migration 
area. In contrast, 7 days after plating almost all 
cells lost nestin expression and became β(III)
tubulin+ or GFAP+ (Figure 2A). Quantification 
of the number of pixels in the respective images 
revealed a 5.5-fold reduction in the number of 
nestin+ pixels/nuclei after 6 more days of dif-
ferentiation (570.9 ± 64 to 103.2 ± 29 pix-
els/nuclei; mean ± SD), whereas in the same 
time period the number of β(III)tubulin+ and 
GFAP+ pixels increased 4.7- and 1.9-fold, 
respectively [β(III)tubulin, from 118.7 ± 27.4 
to 509.6 ± 55 pixels/nuclei; GFAP, from 250.8 
± 56 to 480.7 ± 198 pixels/nuclei; Figure 2A]. 
Furthermore, the immuno  cyto  chemical stain-
ing for β(III)tubulin suggests that neuronal 
cells may form connections and thus build 
neuronal networks (Figure 2A).
Another cell type emerging from neu-
ral precursor cells are O4+ oligodendrocytes. 
They form within the neurosphere (Fritsche 
et al. 2005) and migrate out of the sphere over 
time. After 2, 4, and 7 days of differentiation, 
3 ± 0.2, 52 ± 1, and 210 ± 5 O4+ cells (mean 
± SD), respectively, were located in the migra-
tion area (Figure 2B). They also changed mor-
phology over time. Although after 48 hr most 
O4+ cells were bipolar, we found more branch-
ing after 4 days; after 7 days of differentiation, 
multi  polar and membrane sheet-forming cells 
were prominent (Figure 2C).
Next, we developed assays that identify 
changes in cell proliferation, differentia  tion, 
migration, and apoptosis by applying model 
chemicals, which are known to interfere with 
normal brain development (Grandjean and 
Landrigan 2006).
Cell proliferation in a neurosphere can 
be determined by counting the number of 
cells per dissociated sphere or by measuring 
the increase in sphere diameter over time. 
Figure 3A shows that there was a very good 
association between these two parameters 
Figure 1. Cellular composition of human neurospheres shown in cryostat sections (10 µm) of proliferating (A and B) and differentiating (8 days after plating; 
C and D) neurospheres (representatives of five spheres for each developmental stage). Nuclei are stained in blue with Hoechst; nestin and β(III)tubulin are 
stained in green; and GFAP is stained in red. Individual antibody stainings are shown as contrast images. Bars = 100 µm.
A B
C DMoors et al.
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(e.g., 2.6 × 103 and 5.3 × 104 cells for spheres 
0.3 and 0.6 mm in diameter, respectively). 
We verified this observation and made the 
method suitable for high-throughput analy-
ses by measuring viability of neuro  spheres 
dependent on sphere diameter with the 
CellTiter-Blue assay. Figure 3B demonstrates 
that viability of spheres correlates well with 
their sizes (e.g., spheres 0.3 and 0.6 mm in 
diameter had 4 × 103 and 8 × 103 relative 
fluorescence units, respectively). Growth of 
neurospheres in the absence or presence of 
20 or 100 ng/mL EGF caused a 1.5 ± 0.4-fold 
or 2.4 ± 0.3-fold induction in viability (mean 
± SD), respectively over 14 days, although 
the same spheres gained 0.08 ± 0.03 or 0.2 
± 0.04 mm in diameter, respectively, during 
this time (Figure 3C,D). We observed no 
differences in proliferation between spheres 
grown in EGF in the presence or absence of 
FGF (data not shown). Cultivation without 
growth factors as a negative control did not 
change size or viability. Thus, this assay can 
assess sphere proliferation.
We verified these data by FACS analy-
ses for DNA content using propidium iodine 
staining. Among all stained cells, 97.75% 
showed only a G0/G1 peak (Figure 3F), 
whereas we found a typical cell cycle distribu-
tion for proliferating cells in only 2.72% of 
the population. About 35% of these were in 
G2/M or S phase (Figure 3F, control), sug-
gesting fast cell-cycling behavior. Indirubin, a 
G2/M blocking agent that blocks signaling of 
cyclin-dependent kinases (Hoessel et al. 1999), 
increased the cell fraction in G2/M phase from 
14% to 37.8% (Figure 3F), whereas with-
drawal of growth factors caused G1 arrest.
To investigate effects of chemicals on dif-
ferentiation, we exposed neurospheres to dif-
ferent Hg compounds. Immunocytochemical 
analyses after 48 hr revealed that migra-
tion areas of control cells consist of 10% 
β(III)tubulin+ cells and 90% GFAP+ cells 
(Moors et al. 2007). MeHgCl (500 and 
750 nM) reduced the amount of β(III)tubu-
lin+ cells to 8 ± 0.17% (mean ± SD) and 2.3 ± 
0.57%, respectively. Exposure to 4 µM HgCl2 
decreased the number of β(III)tubulin+ cells 
to 4.7 ± 2.3%. In contrast, cAMP increased 
the formation of β(III)tubulin+ cells to 165.4 
± 9% of control cells (Figure 4).
Next, we investigated the effects of Hg on 
cell migration with the neurosphere migra-
tion assay (Moors et al. 2007). Exposure to 
MeHgCl (500 nM) caused an inhibition 
of cell migration to 78.7% ± 7% of control 
values, which was further reduced by higher 
MeHgCl concentrations. HgCl2 (4 µM) also 
reduced cell migration to 73.6 ± 13% of the 
controls (Figure 5A, B). Notably, cell migra-
tion was significantly affected by noncytotoxic 
Hg concentrations (Figure 5C).
To determine whether human neuro-
spheres can be stimulated to undergo apopto-
sis, we exposed them to staurosporine, a potent 
inducer of the intrinsic apoptotic pathway via 
cytochrome c release followed by activation of 
the caspase cascade (Slee et al. 2000), or H2O2, 
a direct reactive oxygen species (ROS) donor, 
for 24 hr. LDH measurements of neurosphere 
supernatants indicate that staurosporine and 
H2O2 induce cell death in a concentration-
dependent manner. However, the human neu-
roblastoma cell line SH-SY5Y (ATCC, Wesel, 
Germany) is more susceptible to stauro-
sporine- and H2O2-induced LDH release than 
are the spheres, as indicated by a higher LDH 
release at lower concentrations, which we 
confirmed using phase-contrast microscopic 
images (Figure 6A,B). To explore whether 
staurosporine (1 µM) or H2O2 (1 mM) 
induced cell death via apoptosis, we performed 
TUNEL assays. Although the basal apopto-
sis rate of hNPCs after 3 days of differentia-
tion was approximately 1% (data not shown), 
both treatments induced TUNEL-positive 
cells, showing that apoptosis is involved in 
staurosporine-induced and H2O2-induced cell 
death (Figure 6D). However, measurements 
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Figure 2. Cellular composition of the neurosphere migration area. (A) Quantification of nestin+, GFAP+, and 
β(III)tubulin+ pixels after 1 and 7 days of differentiation (mean ± SD) and representative photo  graphs [left: nes-
tin (green), GFAP (red); right: β(III)tubulin (green), GFAP (red)]. Ten individual spheres were included in each 
calculation. (B) Quantification of migrated O4+ cells, counted manually after 2, 4, and 7 days of differentiation in 
six individual spheres (mean ± SD). (C) Morphology of O4+ cells at different time points. Bars = 100 µm.
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of effector caspase-3/-7 activities indicate that 
staurosporine-induced cell death is caspase 
dependent, whereas H2O2-triggered cell death 
is caspase independent (Figure 6C).
Discussion
In humans, DNT results in learning deficits 
and mental retardation (Hass 2006; Schettler 
2001). Furthermore, various clinical dis  orders 
(e.g., schizophrenia, autism) are results of inter-
ference with normal brain development, and 
their etiologies are suspected to also imply 
environmental components (Rice and Barone 
2000). To prevent harm, it is crucial to under-
stand DNT potentials of chemicals, and thus 
testing is necessary. Therefore, we established 
and characterized this three-dimensional 
human neuro  sphere system that imitates the 
basic processes of brain development—prolifer-
ation, differentiation, and migration [Figure 2; 
see also Supplemental Material, Figures 1 
and 2 (available at http://www.ehponline.org/
members/2009/0800207/suppl.pdf)].
Individual spheres in single wells of 
a 96-well plate proliferated over time, and 
FACS analyses of propidium iodine–stained 
neurosphere single-cell suspensions revealed 
that approximately 2.72% of sphere cells went 
through S-phase of the cell cycle, confirm-
ing their proliferative capacity (Figure 3E,F). 
This is in agreement with Reynold and Rietze 
(2005), who found 2.4% of human neuro-
sphere cells capable of proliferation as assessed 
by a single-cell clono  genic assay.
To illuminate the inside of the “black-
box” neurosphere, we immuno  cyto  chemically 
stained proliferating spheres. Microscopic 
analy  ses illustrate a zonal distribution of nes-
tin+ hNPCs in the periphery and later GFAP+ 
and β(III)tubulin+ astrocytes and neurons in 
the center of the sphere (Figure 1). These find-
ings are similar to data reported for murine 
neuro  spheres (Campos et al. 2004) and might 
be caused by a growth factor gradient from 
the sphere periphery to its inside. One could 
specu  late that this zonal distribution resembles 
an “outside-in” brain structure, with nestin+ 
cells representing the proliferative zone of the 
brain, which is in proximity to the growth-fac-
tor–containing liquor of the ventricles, and the 
GFAP+ and β(III)tubulin+ cells in the center 
of the sphere resembling superficial regions of 
the cortex (Campos et al. 2004). Whether the 
growth factor gradient is in fact responsible for 
zonal dissemination within a neurosphere is a 
subject for future investigations.
Growth factor withdrawal and presence of 
a poly-d-lysine/laminin matrix initiate cellular 
migration out of the sphere (Moors et al. 2007). 
Observation of initial migration over 24 hr by 
real-time phase-contrast microscopy illustrates 
that radial as well as tangential migration 
happens during this time [see Supplemental 
Material, Figure 2 (available at http://www.
ehponline.org/members/2009/0800207/suppl.
pdf)]. The cues causing cells to connect, dis-
connect, and move forward, backward, and 
even tangentially in vitro are so far unknown. 
Directed migration in vivo is motivated by 
chemical gradients of, for example, Netrin1/
UNC6, semaphorins, or the reelin/dab1 path-
way (Hatten 2002). Although some of these 
Figure 3. Assessment of neurosphere proliferation. RFU, relative fluorescence units. (A) Correlation between sphere diameter and number of cells/sphere 
(R2 = 0.9926). (B) Correlation between sphere size and metabolic activity; reductase activity was measured with the CellTiter-Blue assay (R2 = 0.983). 
(C) Measurement of sphere proliferation by assessing metabolic activity repetitively over time. (D) Assessment of proliferation in the same spheres shown in (C) 
by measuring sphere diameter over time. Results in (C) and (D) are typical representatives of three independent experiments at each time point shown as mean 
± SD of 3–6 individual spheres. (E) FACS analysis of dissociated, fixed, and propidium iodine–stained neurospheres. The circled regions depict subpopulations; 
one contained proliferating cells (see second DNA histogram). (F) DNA content histograms of the proliferating cell population. The control histogram corre-
sponds to cells cultured with EGF and FGF. A G2/M or G1 arrest was induced with indirubin (28 hr) or by withdrawal growth factor (96 hr).
*p ≤ 0.05.
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Figure 5. Mercury inhibits neurosphere migration. Phase-contrast images (A) and the respective quantifications (B) of cell migration (migration distance meas  ured 
with an object micrometer from the edge of the sphere to the farthest outgrowth). In (A), bars = 100 µm. (C) Cell viability as assessed with the CellTiter-Blue assay. 
In (B) and (C), data are mean ± SD of at least three independent experiments (3–5 spheres/experiment).
*p < 0.05.
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gene products, such as different semaphorins, 
are expressed in our neurospheres (Moors M, 
Fritsche E, unpublished data), whether such 
attractants or repellants are responsible for 
the directed migration we observe in vitro has 
to be further investigated. Nevertheless, the 
distance that differentiating hNPCs migrate 
over time is highly robust and reproducible. 
Migration speed is independent of neurosphere 
size and does not differ between three inde-
pendent donors tested so far [gestational weeks 
16–19; see Supplemental Material, Figure 1 
(available at http://www.ehponline.org/
members/2009/0800207/suppl.pdf)]. A faster 
migration speed (1 mm/24 hr) was reported 
for neurospheres that were prepared from post-
natal brain cortices of pre  mature infants (ges-
tational weeks 23–25; Flanagan et al. 2006). 
This difference might be due to distinct culture 
conditions or ages of individuals.
During cellular outgrowth, hNPCs differ-
entiate into GFAP+, O4+, and β(III)tubulin+ 
glial- and neuronal-like cells while losing nes-
tin staining (Figure 2A). The ratio of approxi-
mately 10% neuronal and 90% glial cells that 
we counted after 2 days of differentiation 
(Moors et al. 2007) resembles the physiologic 
distribution of brain cells in humans (Baumann 
and Pham-Dinh 2001). Furthermore, we 
found O4+ oligo  dendro  cyte precursor cells in 
the migration area that increase in number and 
degree of morphologic maturation over time 
(Figure 2) (Baumann and Pham-Dinh 2001). 
These differentiation results point to culture 
maturation.
For the development of in vitro assays that 
identify chemicals with DNT potential, we 
employed Hg, which is a human developmen-
tal neuro  toxicant (Grandjean and Landrigan 
2006). Prenatal Hg poisoning causes develop-
mental delays, mental retardation, and adverse 
effects on memory and motor skills in chil-
dren (Sanfeliu et al. 2003; Schettler 2001). 
Neuropathologic examinations revealed 
microcephaly and global brain disorganiza-
tion resulting from disturbances in cell migra-
tion and division (Clarkson 2002; Schettler 
2001). Moreover, postmortem brains had 
a decreased number of nerve cells (Castoldi 
et al. 2001; Choi 1989). We mimicked these 
effects in vitro by treating neuro  spheres with 
organic Hg and inorganic Hg, which were 
identified in human brain sections (Clarkson 
2002). Hg decreased the migration distance 
(Figure 5A,B) and increased the glial cell/neu-
ron ratio (Figure 4). We observed these effects 
at non  cytotoxic concentrations, pointing to 
a target-cell–specific effect (Figure 5C). How 
do these findings correspond to Hg exposures 
in humans? From an Hg poisoning incident 
in Iraq, a lowest observed adverse effect level 
(LOAEL) for brain MeHg content in intoxi-
cated mothers was calculated to be 800 ng/g, 
a level that caused neurologic symptoms in 
children (Clarkson 1993). Considering the 
measure  ments of Lewandowski et al. (2003), 
who determined cellular in vitro concentra-
tions relative to corresponding medium Hg 
concentrations, this LOAEL is equivalent to 
an in vitro medium concentration of approxi-
mately 266 nM. MeHg accumulation in the 
fetus is higher than in adult organs, implying 
that the LOAEL is under- rather than over-
estimated. In vitro exposure of rodent neu-
ral stem cells to HgCl2 (7–18 µM) or MeHg 
(2.5–5 nM) also resulted in reduced neuronal 
differentiation (Cedrola et al. 2003; Tamm 
et al. 2006). Although the sensitivity toward 
inorganic Hg was similar in human compared 
with mouse spheres (Cedrola et al. 2003), 
rodent stem cells treated for 7 days were more 
sensitive toward organic Hg than were human 
cultures treated for 2 days (Tamm et al. 2006). 
Although both mercuric compounds exert 
adverse effects by binding to sulf  hydryl groups 
of proteins (Clarkson 1972), one further mode 
of action of organic Hg is the induction of 
oxidative stress (Sarafian and Verity 1991; 
Yee and Choi 1994). Antioxidant defenses are 
low in human embryonic brains and evolve 
during develop  ment (Buonocore et al. 2001). 
Furthermore, there might also be species dif-
ferences in defense capacities (Knobloch et al. 
2008). Thus, the differences between our and 
previously published results for MeHg could be 
due to the age of cultures (stem vs. fetal cells), 
species differences, or varying exposure times.
In contrast to Hg, cAMP, a well-described 
compound for inducing neuronal differentia-
tion (Deng et al. 2001), caused an increased 
number of β(III)tubulin+ cells in differenti-
ated hNPCs (Figure 4A), demonstrating the 
dynamic ability of the cell system.
Deregulation of apoptosis results in 
develop  mental brain pathology or neuro-
degenerative diseases (Rodier 1995). 
Furthermore, oxidative stress induces apop-
tosis in many different cells types. Therefore, 
we attempted to trigger ROS-induced pro-
grammed cell death in hNPC cells. Although 
staurosporine induced caspase-dependent 
apoptosis, 1 mM H2O2 induced TUNEL+ 
apoptotic cells without caspase-3/-7 activa-
tion, indicating that neuro  spheres undergo 
caspase-independent apoptosis (Figure 6). 
This is in concert with studies in primary rat 
cerebellar granule cells, which also responded 
with caspase-independent apoptosis to H2O2 
(Dare et al. 2001). Furthermore, comparison 
of LDH activity of human hNPCs with the 
human neuroblastoma SH-SY5Y tumor cell 
line suggests that hNPCs are less sensitive 
toward oxidative stress than are SH-SY5Y 
tumor cells. These data also support observa-
tions that cancer cells are more susceptible to 
various stressors than are normal cells (Aykin-
Burns et al. 2008; Hileman et al. 2004). 
Besides inducing apoptosis, preconditioning 
of mouse NPCs with a low concentration of 
H2O2 (5 µM) is cyto  protective (Sharma et al. 
2008). Whether this is also true for hNPCs or 
even tumor cell lines needs to be investigated.
In summary, we have shown that a) pro-
liferation, migration, differentiation, and 
apoptosis of human neurospheres can be 
quantified; b) in vivo effects of the develop-
mental neuro  toxicant Hg are imitated in vitro; 
and c) the methods applied are suitable for 
medium-throughput screening. Thus, our 
three-dimensional neurospheres offer a new, 
human, system-based method for DNT haz-
ard identification. However, their applica-
bility is limited to basic processes of brain 
development, because they do not resemble 
complex higher brain structure development 
such as formation of cortical layers. Moreover, 
they are limited in their potential to perform 
drug metabolism, as is fetal tissue in vivo. 
For including “maternal metabolism” in the 
in vitro system, strategies such as incubation 
with S9 mixes or hepatocyte coculture have to 
be established.
In the future, more chemicals known to 
cause DNT will be tested for their potential to 
interfere with human neurosphere performance 
to develop this method into a validation pro-
cess and make it applicable for testing needs.
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